Literature DB >> 8203373

Hyperbaric oxygen therapy in calciphylaxis-induced skin necrosis in a peritoneal dialysis patient.

N Vassa1, Z J Twardowski, J Campbell.   

Abstract

A 58-year-old white woman on continuous ambulatory peritoneal dialysis for 2 years developed calciphylaxis-induced necrotic skin lesions over both lower extremities. Despite subtotal parathyroidectomy and other conventional measures, skin lesions continued to worsen. Mapping of transcutaneous oxygen pressure showed markedly low values in involved areas. Skin ulcers completely healed after 38 sessions of hyperbaric oxygen therapy. The results in our case indicate that hyperbaric oxygen therapy may be useful in the treatment of skin ulcers secondary to calciphylaxis.

Entities:  

Mesh:

Year:  1994        PMID: 8203373     DOI: 10.1016/s0272-6386(12)80145-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  Calciphylaxis.

Authors:  R V Mathur; J R Shortland; A M el-Nahas
Journal:  Postgrad Med J       Date:  2001-09       Impact factor: 2.401

Review 2.  [Cutaneous calciphylaxis].

Authors:  U Wollina
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

3.  Patient Outcomes and Factors Associated with Healing in Calciphylaxis Patients Undergoing Adjunctive Hyperbaric Oxygen Therapy.

Authors:  Norman McCulloch; Susan M Wojcik; Marvin Heyboer
Journal:  J Am Coll Clin Wound Spec       Date:  2016-08-30

Review 4.  Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; Suresh C Tyagi; Lisa Kolb; James R Sowers; Ramesh Khanna
Journal:  Cardiovasc Diabetol       Date:  2005-03-18       Impact factor: 9.951

5.  The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism.

Authors:  Zain Khalpey; Matthew A Nehs; Andrew W ElBardissi; Marcus Semel; Stefan G Tullius
Journal:  NDT Plus       Date:  2009-09-08

6.  Hyperbaric oxygen as effective adjuvant therapy in the treatmentof distal calcific uraemic arteriolopathy.

Authors:  Natasha M Rogers; Sean H Chang; David J O Teubner; Patrick T H Coates
Journal:  NDT Plus       Date:  2008-05-13

7.  Calciphylaxis in a 33-year-old man with end-stage renal disease.

Authors:  Khalid M Al-Ghamdi
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526

8.  Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kitravee Kongnatthasate; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-10-09

9.  Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient.

Authors:  Nimisha Amin; Elsa Gonzalez; Michael Lieber; Isidro B Salusky; Joshua J Zaritsky
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

10.  Successful Management of Calciphylaxis in a Kidney Transplant Patient: Case Report.

Authors:  Thomas Welte; Frederic Arnold; Kristin Technau-Hafsi; Elke Neumann-Haefelin; Rika Wobser; Stefan Zschiedrich; Gerd Walz; Albrecht Kramer-Zucker
Journal:  Transplant Direct       Date:  2016-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.